1. Home
  2. INTS vs SRM Comparison

INTS vs SRM Comparison

Compare INTS & SRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INTS
  • SRM
  • Stock Information
  • Founded
  • INTS 2012
  • SRM 1979
  • Country
  • INTS United States
  • SRM United States
  • Employees
  • INTS N/A
  • SRM N/A
  • Industry
  • INTS Biotechnology: Pharmaceutical Preparations
  • SRM
  • Sector
  • INTS Health Care
  • SRM
  • Exchange
  • INTS Nasdaq
  • SRM Nasdaq
  • Market Cap
  • INTS 8.7M
  • SRM 9.0M
  • IPO Year
  • INTS 2023
  • SRM 2023
  • Fundamental
  • Price
  • INTS $0.50
  • SRM $0.43
  • Analyst Decision
  • INTS Strong Buy
  • SRM
  • Analyst Count
  • INTS 3
  • SRM 0
  • Target Price
  • INTS $8.50
  • SRM N/A
  • AVG Volume (30 Days)
  • INTS 396.2K
  • SRM 575.8K
  • Earning Date
  • INTS 05-13-2025
  • SRM 05-09-2025
  • Dividend Yield
  • INTS N/A
  • SRM N/A
  • EPS Growth
  • INTS N/A
  • SRM N/A
  • EPS
  • INTS N/A
  • SRM N/A
  • Revenue
  • INTS N/A
  • SRM $4,394,659.00
  • Revenue This Year
  • INTS N/A
  • SRM N/A
  • Revenue Next Year
  • INTS N/A
  • SRM N/A
  • P/E Ratio
  • INTS N/A
  • SRM N/A
  • Revenue Growth
  • INTS N/A
  • SRM N/A
  • 52 Week Low
  • INTS $0.50
  • SRM $0.26
  • 52 Week High
  • INTS $5.28
  • SRM $1.66
  • Technical
  • Relative Strength Index (RSI)
  • INTS 18.57
  • SRM 54.35
  • Support Level
  • INTS $0.46
  • SRM $0.40
  • Resistance Level
  • INTS $0.59
  • SRM $0.45
  • Average True Range (ATR)
  • INTS 0.05
  • SRM 0.04
  • MACD
  • INTS 0.02
  • SRM 0.00
  • Stochastic Oscillator
  • INTS 21.14
  • SRM 70.71

About INTS Intensity Therapeutics Inc. Common stock

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

About SRM SRM Entertainment Inc.

SRM Entertainment Inc is a trusted toy and souvenir designer and developer, selling into theme parks and entertainment venues. It has developed, manufactured, and supplied the entertainment and amusement park industry with exclusive products that are often only available to consumers inside SRM's customer base venues such as Walt Disney Parks and Resorts, Universal Studios, SeaWorld, Six Flags, Great Wolf Lodge, Dollywood, and Merlin Entertainment. Its product category includes The Smurfs and Zoonicorns, Sammy Sloth, lilita Llama, kyle Koala, and Hanna Hedgehog.

Share on Social Networks: